Trichostatin A and Cyclin D1 Degradation in Breast Cancer Cells
Author Information
Author(s): John P. Alao, Alexandra V. Stavropoulou, Eric W-F Lam, Charles Coombes, David M. Vigushin
Primary Institution: Imperial College, Hammersmith Hospital
Hypothesis
Does the histone deacetylase inhibitor trichostatin A induce degradation of cyclin D1 in MCF-7 breast cancer cells?
Conclusion
Trichostatin A induces rapid degradation of cyclin D1 in MCF-7 cells through a GSK3β-mediated pathway.
Supporting Evidence
- Trichostatin A treatment leads to the rapid degradation of cyclin D1 in MCF-7 cells.
- GSK3β-mediated phosphorylation is necessary for cyclin D1 degradation.
- Inhibition of the proteasome prevents cyclin D1 degradation induced by trichostatin A.
Takeaway
A drug called trichostatin A helps get rid of a protein called cyclin D1 in breast cancer cells, which can help stop the cancer from growing.
Methodology
The study used MCF-7 breast cancer cells to investigate the effects of trichostatin A on cyclin D1 degradation, employing various inhibitors and mutagenesis techniques.
Limitations
The study does not fully explore the alternative pathways for cyclin D1 degradation independent of GSK3β.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website